Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Kurzrock R

Collect these papers and discover other ones on Labmeeting. Learn more.

Sulforaphane inhibits angiogenesis through activation of FOXO transcription factors.

+ cite this

+ View Abstract

Davis R, Singh KP, Kurzrock R, and Shankar S

Oncology reports 22(6):1473-8, 2009 Dec - Who cited this? | PubMed ID: 19885601 | Fulltext

Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer.

+ cite this

+ View Abstract

Meng Z, Yang P, Shen Y, Bei W, Zhang Y, Ge Y, Newman RA, Cohen L, Liu L, Thornton B, Chang DZ, Liao Z, and Kurzrock R

Cancer 115(22):5309-18, 2009 Nov 15 - Who cited this? | PubMed ID: 19701908 | Fulltext

Could Antitumor Activity of Curcumin in Patients Be due to Its Metabolites? A Response.

+ cite this

Dhillon N, Sung B, Kurzrock R, and Aggarwal BB

Clinical cancer research : an official journal of the American Association for Cancer Research 15(22):7108-9, 2009 Nov 15 - Who cited this? | PubMed ID: 19903781 | Fulltext

Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies.

+ cite this

+ View Abstract

Hong DS, Sebti SM, Newman RA, Blaskovich MA, Ye L, Gagel RF, Moulder S, Wheler JJ, Naing A, Tannir NM, Ng CS, Sherman SI, El Naggar AK, Khan R, Trent J, Wright JJ,

(show remaining authors)

Clinical cancer research : an official journal of the American Association for Cancer Research 15(22):7061-8, 2009 Nov 15 - Who cited this? | PubMed ID: 19903778 | Fulltext

Phase I clinical trials in 56 patients with thyroid cancer: the m. D. Anderson cancer center experience.

+ cite this

+ View Abstract

Tsimberidou AM, Vaklavas C, Wen S, Hong D, Wheler J, Ng C, Naing A, Tse S, Busaidy N, Markman M, Sherman SI, and Kurzrock R

The Journal of clinical endocrinology and metabolism 94(11):4423-32, 2009 Nov - Who cited this? | PubMed ID: 19820016 | Fulltext

Project zero delay: a process for accelerating the activation of cancer clinical trials.

+ cite this

+ View Abstract

Kurzrock R, Pilat S, Bartolazzi M, Sanders D, Van Wart Hood J, Tucker SD, Webster K, Mallamaci MA, Strand S, Babcock E, and Bast RC

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(26):4433-40, 2009 Sep 10 - Who cited this? | PubMed ID: 19652061 | Fulltext

Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2.

+ cite this

+ View Abstract

Evans DG, Kalamarides M, Hunter-Schaedle K, Blakeley J, Allen J, Babovic-Vuskanovic D, Belzberg A, Bollag G, Chen R, DiTomaso E, Golfinos J, Harris G, Jacob A, Kalpana G, Karajannis M, Korf B,

(show remaining authors)

Clinical cancer research : an official journal of the American Association for Cancer Research 15(16):5032-9, 2009 Aug 15 - Who cited this? | PubMed ID: 19671848 | Fulltext

Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors.

+ cite this

+ View Abstract

Herbst RS, Hong D, Chap L, Kurzrock R, Jackson E, Silverman JM, Rasmussen E, Sun YN, Zhong D, Hwang YC, Evelhoch JL, Oliner JD, Le N, and Rosen LS

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(21):3557-65, 2009 Jul 20 - Who cited this? | PubMed ID: 19546406 | Fulltext

A phase I clinical trial of darinaparsin in patients with refractory solid tumors.

+ cite this

+ View Abstract

Tsimberidou AM, Camacho LH, Verstovsek S, Ng C, Hong DS, Uehara CK, Gutierrez C, Daring S, Stevens J, Komarnitsky PB, Schwartz B, and Kurzrock R

Clinical cancer research : an official journal of the American Association for Cancer Research 15(14):4769-76, 2009 Jul 15 - Who cited this? | PubMed ID: 19584162 | Fulltext

Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience.

+ cite this

+ View Abstract

Vemulapalli S, Chintala L, Tsimberidou AM, Dhillon N, Lei X, Hong D, and Kurzrock R

American journal of hematology 84(7):408-13, 2009 Jul - Who cited this? | PubMed ID: 19437507 | Fulltext

Reply to j.j.L. Jacobs et Al.

+ cite this

Stewart DJ and Kurzrock R

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(18):3063-4, 2009 Jun 20 - Who cited this? | PubMed ID: 19398562 | Fulltext

Decitabine effect on tumor global DNA methylation and other parameters in a phase I trial in refractory solid tumors and lymphomas.

+ cite this

+ View Abstract

Stewart DJ, Issa JP, Kurzrock R, Nunez MI, Jelinek J, Hong D, Oki Y, Guo Z, Gupta S, and Wistuba II

Clinical cancer research : an official journal of the American Association for Cancer Research 15(11):3881-8, 2009 Jun 1 - Who cited this? | PubMed ID: 19470736 | Fulltext

Electronic clinical challenges and images in GI. Image 2. Extensive bilateral extracranial subcutaneous fluid collection.

+ cite this

Braiteh F and Kurzrock R

Gastroenterology 136(7):e3-6, 2009 Jun - Who cited this? | PubMed ID: 19427926 | Fulltext

Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.

+ cite this

+ View Abstract

Shankar S, Davis R, Singh KP, Kurzrock R, Ross DD, and Srivastava RK

Molecular cancer therapeutics 8(6):1596-605, 2009 Jun - Who cited this? | PubMed ID: 19509267 | Fulltext

Determination of minimum effective dose and optimal dosing schedule for liposomal curcumin in a xenograft human pancreatic cancer model.

+ cite this

+ View Abstract

Mach CM, Mathew L, Mosley SA, Kurzrock R, and Smith JA

Anticancer research 29(6):1895-9, 2009 Jun - Who cited this? | PubMed ID: 19528445 | Fulltext

The changing face of Phase 1 cancer clinical trials: new challenges in study requirements.

+ cite this

+ View Abstract

Craft BS, Kurzrock R, Lei X, Herbst R, Lippman S, Fu S, and Karp DD

Cancer 115(8):1592-7, 2009 Apr 15 - Who cited this? | PubMed ID: 19165808 | Fulltext

Survival of patients in a Phase 1 clinic: the M. D. Anderson Cancer Center Experience.

+ cite this

+ View Abstract

Wheler J, Tsimberidou AM, Hong D, Naing A, Jackson T, Liu S, Feng L, and Kurzrock R

Cancer 115(5):1091-9, 2009 Mar 1 - Who cited this? | PubMed ID: 19165805 | Fulltext

Molecular imaging of Bcr-Abl phosphokinase in a xenograft model.

+ cite this

+ View Abstract

Wu JY, Yang DJ, Angelo LS, Kohanim S, and Kurzrock R

Molecular cancer therapeutics 8(3):703-10, 2009 Mar - Who cited this? | PubMed ID: 19258427 | Fulltext

Turmeric and green tea: a recipe for the treatment of B-chronic lymphocytic leukemia.

+ cite this

+ View Abstract

Angelo LS and Kurzrock R

Clinical cancer research : an official journal of the American Association for Cancer Research 15(4):1123-5, 2009 Feb 15 - Who cited this? | PubMed ID: 19228716 | Fulltext

Poor prognosis in non-Caucasian patients with early-onset mycosis fungoides.

+ cite this

+ View Abstract

Sun G, Berthelot C, Li Y, Glass DA, George D, Pandya A, Kurzrock R, and Duvic M

Journal of the American Academy of Dermatology 60(2):231-5, 2009 Feb - Who cited this? | PubMed ID: 19026464 | Fulltext

Cancer: the road to amiens.

+ cite this

Stewart DJ and Kurzrock R

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(3):328-33, 2009 Jan 20 - Who cited this? | PubMed ID: 19064964 | Fulltext

[In Process Citation].

+ cite this

Kurzrock R and Dhillon N

Clinical cancer research : an official journal of the American Association for Cancer Research 15(2):747, 2009 Jan 15 - Who cited this? | PubMed ID: 19147783 | Fulltext

The role of investigational therapy in management of patients with advanced metastatic malignancy.

+ cite this

Freireich EJ and Kurzrock R

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(2):304-6, 2009 Jan 10 - Who cited this? | PubMed ID: 19064962 | Fulltext

The Influence of Tumor Necrosis Factor-{alpha} -308 G/A and IL-6 -174 G/C on Pain and Analgesia Response in Lung Cancer Patients Receiving Supportive Care.

+ cite this

+ View Abstract

Reyes-Gibby CC, El Osta B, Spitz MR, Parsons H, Kurzrock R, Wu X, Shete S, and Bruera E

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 17(11):3262-7, 2008 Nov - Who cited this? | PubMed ID: 18990769 | Fulltext

Phase I study of epigenetic modulation with 5-azacytidine and valproic acid in patients with advanced cancers.

+ cite this

+ View Abstract

Braiteh F, Soriano AO, Garcia-Manero G, Hong D, Johnson MM, Silva Lde P, Yang H, Alexander S, Wolff J, and Kurzrock R

Clinical cancer research : an official journal of the American Association for Cancer Research 14(19):6296-301, 2008 Oct 1 - Who cited this? | PubMed ID: 18829512 | Fulltext

Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: Lessons from the first clinical trials.

+ cite this

+ View Abstract

Rodon J, Desantos V, Ferry RJ, and Kurzrock R

Molecular cancer therapeutics 7(9):2575-88, 2008 Sep - Who cited this? | PubMed ID: 18790742 | Fulltext

The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes.

+ cite this

+ View Abstract

Tsimberidou AM, Estey E, Wen S, Pierce S, Kantarjian H, Albitar M, and Kurzrock R

Cancer, 2008 Aug 5 - Who cited this? | PubMed ID: 18683214 | Fulltext

Molecular epidemiology, cancer-related symptoms, and cytokines pathway.

+ cite this

+ View Abstract

Reyes-Gibby CC, Wu X, Spitz M, Kurzrock R, Fisch M, Bruera E, and Shete S

The lancet oncology 9(8):777, 2008 Aug - Who cited this? | PubMed ID: 18672213 | Fulltext

Phase II trial of curcumin in patients with advanced pancreatic cancer.

+ cite this

+ View Abstract

Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V, and Kurzrock R

Clinical cancer research : an official journal of the American Association for Cancer Research 14(14):4491-9, 2008 Jul 15 - Who cited this? | PubMed ID: 18628464 | Fulltext

Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib.

+ cite this

Braiteh F, Kurzrock R, and Johnson FM

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 26(20):3460-2, 2008 Jul 10 - Who cited this? | PubMed ID: 18612164 | Fulltext

Multiple squamous cell carcinomas of the skin after therapy with sorafenib combined with tipifarnib.

+ cite this

+ View Abstract

Hong DS, Reddy SB, Prieto VG, Wright JJ, Tannir NM, Cohen PR, Diwan AH, Evans HL, and Kurzrock R

Archives of dermatology 144(6):779, 2008 Jun - Who cited this? | PubMed ID: 18559769 | Fulltext

Medullary thyroid cancer: targeting the RET kinase pathway with sorafenib/tipifarnib.

+ cite this

+ View Abstract

Hong D, Ye L, Gagel R, Chintala L, El Naggar AK, Wright J, and Kurzrock R

Molecular cancer therapeutics 7(5):1001, 2008 May - Who cited this? | PubMed ID: 18445656 | Fulltext

Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells.

+ cite this

+ View Abstract

Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH, and Kurzrock R

Molecular cancer therapeutics 7(3):464, 2008 Mar - Who cited this? | PubMed ID: 18347134 | Fulltext

Increased cancer antigen 27.29 (CA27.29) level in patients with mycosis fungoides.

+ cite this

+ View Abstract

Cen P, Duvic M, Cohen PR, and Kurzrock R

Journal of the American Academy of Dermatology 58(3):382-6, 2008 Mar - Who cited this? | PubMed ID: 18280334 | Fulltext

The immunocytokine scFv23/TNF targeting HER-2/neu induces synergistic cytotoxic effects with 5-fluorouracil in TNF-resistant pancreatic cancer cell lines.

+ cite this

+ View Abstract

Lyu MA, Kurzrock R, and Rosenblum MG

Biochemical pharmacology 75(4):836-46, 2008 Feb 15 - Who cited this? | PubMed ID: 18082672 | Fulltext

Phase I study of alternate-week administration of tipifarnib in patients with myelodysplastic syndrome.

+ cite this

+ View Abstract

Kurzrock R, Kantarjian HM, Blascovich MA, Bucher C, Verstovsek S, Wright JJ, Pilat SR, Cortes JE, Estey EH, Giles FJ, Beran M, and Sebti SM

Clinical cancer research : an official journal of the American Association for Cancer Research 14(2):509-14, 2008 Jan 15 - Who cited this? | PubMed ID: 18223226 | Fulltext

Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia.

+ cite this

+ View Abstract

Tsimberidou AM, Wierda WG, Plunkett W, Kurzrock R, O'Brien S, Wen S, Ferrajoli A, Ravandi-Kashani F, Garcia-Manero G, Estrov Z, Kipps TJ, Brown JR, Fiorentino A, Lerner S, Kantarjian HM, and Keating MJ

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 26(2):196-203, 2008 Jan 10 - Who cited this? | PubMed ID: 18182662 | Fulltext

Cytokine Genes and Pain Severity in Lung Cancer: Exploring the Influence of TNF-{alpha}-308 G/A IL6-174G/C and IL8-251T/A.

+ cite this

+ View Abstract

Reyes-Gibby CC, Spitz M, Wu X, Merriman K, Etzel C, Bruera E, Kurzrock R, and Shete S

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 16(12):2745-51, 2007 Dec - Who cited this? | PubMed ID: 18086782 | Fulltext

Interleukin-6 and its receptor in cancer: implications for Translational Therapeutics.

+ cite this

+ View Abstract

Hong DS, Angelo LS, and Kurzrock R

Cancer 110(9):1911-28, 2007 Nov 1 - Who cited this? | PubMed ID: 17849470 | Fulltext

Cutaneous castleman's disease responds to anti interleukin-6 treatment.

+ cite this

+ View Abstract

Ahmed B, Tschen JA, Cohen PR, Zaki MH, Rady PL, Tyring SK, Corringham RE, and Kurzrock R

Molecular cancer therapeutics 6(9):2386-90, 2007 Sep - Who cited this? | PubMed ID: 17766835 | Fulltext

Studies in target-based treatment.

+ cite this

Kurzrock R

Molecular cancer therapeutics 6(9):2385, 2007 Sep - Who cited this? | PubMed ID: 17846118 | Fulltext

Safety, pharmacokinetics, and efficacy of AMG 706, an oral multikinase inhibitor, in patients with advanced solid tumors.

+ cite this

+ View Abstract

Rosen LS, Kurzrock R, Mulay M, Van Vugt A, Purdom M, Ng C, Silverman J, Koutsoukos A, Sun YN, Bass MB, Xu RY, Polverino A, Wiezorek JS, Chang DD, Benjamin R, and Herbst RS

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 25(17):2369, 2007 Jun 10 - Who cited this? | PubMed ID: 17557949 | Fulltext

Pilot study of regional, hepatic intra-arterial paclitaxel in patients with breast carcinoma metastatic to the liver.

+ cite this

+ View Abstract

Camacho LH, Kurzrock R, Cheung A, Barber DF, Gupta S, Madoff DC, Wallace MJ, Kim EE, Curley SA, Hortobagyi GN, and Mavligit G

Cancer 109(11):2190-6, 2007 Jun 1 - Who cited this? | PubMed ID: 17464952 | Fulltext

A multicenter phase 2 study of the farnesyltransferase inhibitor tipifarnib in intermediate- to high-risk myelodysplastic syndrome.

+ cite this

+ View Abstract

Fenaux P, Raza A, Mufti GJ, Aul C, Germing U, Kantarjian H, Cripe L, Kerstens R, De Porre P, and Kurzrock R

Blood 109(10):4158-63, 2007 May 15 - Who cited this? | PubMed ID: 17264294 | Fulltext

Vascular endothelial growth factor and its relationship to inflammatory mediators.

+ cite this

+ View Abstract

Angelo LS and Kurzrock R

Clinical cancer research : an official journal of the American Association for Cancer Research 13(10):2825-30, 2007 May 15 - Who cited this? | PubMed ID: 17504979 | Fulltext

Studies in target-based treatment.

+ cite this

+ View Abstract

Kurzrock R

Molecular cancer therapeutics 6(5):1477, 2007 May - Who cited this? | PubMed ID: 17483434 | Fulltext

Improving the institutional submission and approval process for clinical research protocols in oncology.

+ cite this

Camacho LH, Marubio L, Purdom MA, Leonard D, Hong DS, Moulder S, Pilat SR, and Kurzrock R

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 25(12):1632, 2007 Apr 20 - Who cited this? | PubMed ID: 17443009 | Fulltext

Uncommon tumors and exceptional therapies: paradox or paradigm?.

+ cite this

+ View Abstract

Braiteh F and Kurzrock R

Molecular cancer therapeutics 6(4):1175-9, 2007 Apr - Who cited this? | PubMed ID: 17431100 | Fulltext

Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer.

+ cite this

+ View Abstract

Li L, Ahmed B, Mehta K, and Kurzrock R

Molecular cancer therapeutics 6(4):1276-82, 2007 Apr - Who cited this? | PubMed ID: 17431105 | Fulltext

CAT scan reveals BAT sign.

+ cite this

Braiteh F, Cohen PR, and Kurzrock R

Lancet 369(9557):217, 2007 Jan 20 - Who cited this? | PubMed ID: 17240288 | Fulltext

Search Google Scholar for Kurzrock R

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!